LeMaitre Vascular (LMAT) vs DENTSPLY SIRONA (XRAY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
LeMaitre Vascular (LMAT) has outperformed DENTSPLY SIRONA (XRAY) over the past year, losing 8.6% versus a loss of 30.7%. Over five years, LMAT leads with a +48.0% price change compared with -85.2% for XRAY. LeMaitre Vascular is the larger company by market cap ($1.82 billion vs $1.70 billion), about 1.1 times the size.
On valuation, DENTSPLY SIRONA trades at a lower forward P/E (5.7x vs 25.0x for LeMaitre Vascular). DENTSPLY SIRONA offers the higher dividend yield (3.76% vs 1.13%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LMAT | XRAY |
|---|---|---|
| Share price | $79.57 | $8.52 |
| Market cap | $1.82B | $1.70B |
| 1-day change | +0.33% | -0.29% |
| YTD return | -2.21% | -25.28% |
| 1-year return | -8.62% | -30.74% |
| 5-year return | +48.02% | -85.24% |
| P/E ratio (TTM) | 27.92 | — |
| Forward P/E | 25.03 | 5.68 |
| EPS (TTM) | $2.85 | $-2.73 |
| Dividend yield | 1.13% | 3.76% |
| Annual dividend | $0.90 | $0.32 |
| 52-week high | $118.01 | $14.76 |
| 52-week low | $78.22 | $8.38 |
| Distance from 52-week high | -32.57% | -42.31% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +34.47% | +57.37% |
| Average volume | 328.65K | 4.73M |
| Shares outstanding | 22.87M | 199.35M |
| Employees | 646 | 14,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LMAT has outperformed XRAY by 22.1 percentage points over the past year.
- DENTSPLY SIRONA offers a meaningfully higher dividend yield (3.76% vs 1.13%).
About LeMaitre Vascular
LMAT stock →LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 646 employees
About DENTSPLY SIRONA
XRAY stock →DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.
Health Care · Medical/Dental Instruments · 14,000 employees
LMAT vs XRAY FAQ
Which is bigger, LeMaitre Vascular or DENTSPLY SIRONA?
LeMaitre Vascular (LMAT) is larger, with a market capitalization of $1.82B compared with $1.70B for DENTSPLY SIRONA (XRAY).
Which stock has performed better over the past year, LMAT or XRAY?
LMAT returned -8.62% over the past 12 months, compared with -30.74% for XRAY (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, LeMaitre Vascular or DENTSPLY SIRONA?
DENTSPLY SIRONA has the higher yield at 3.76%, compared with 1.13% for LeMaitre Vascular.
Are LeMaitre Vascular and DENTSPLY SIRONA in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.